Ring chromosome 12 syndrome

Ring chromosome 12 syndrome (also referred to as r(12) syndrome) is an extremely rare chromosomal disorder in which one copy of chromosome 12 forms a ring structure instead of its normal linear configuration. This ring formation occurs when both ends of the chromosome break off and the remaining ends fuse together, typically resulting in the loss of genetic material from the short arm (12p) and/or long arm (12q) of chromosome 12. The clinical consequences depend on the amount and location of deleted genetic material, as well as the degree of ring chromosome instability during cell division. The syndrome primarily affects growth, neurodevelopment, and craniofacial structures. Key clinical features commonly reported include short stature, intellectual disability of variable severity, microcephaly, facial dysmorphism (such as a broad or flat nasal bridge, epicanthal folds, low-set ears, and micrognathia), and developmental delay. Some patients may also present with skeletal anomalies, cardiac defects, and skin findings such as café-au-lait spots. Growth retardation is frequently observed both prenatally and postnatally. The phenotypic spectrum is broad, and severity can vary considerably between affected individuals, partly due to differences in the extent of chromosomal material lost and the presence of mosaicism. There is no specific cure or targeted therapy for ring chromosome 12 syndrome. Management is supportive and symptom-based, involving early intervention programs, speech and occupational therapy, special education services, and regular monitoring of growth and development. Cardiac and skeletal anomalies, if present, may require surgical or orthopedic intervention. Genetic counseling is recommended for affected families to discuss recurrence risk and prognosis.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Ring chromosome 12 syndrome